Vol. 30.Issue. 1. January - February 2018 | Clínica e Investigación en Arteriosclerosis (English Edition)

ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Clínica e Investigación en Arteriosclerosis has received its first journal Impact Factor (JCR) in 2023. Instructions for authors - Submit an article

"Methodological Notes": a new and important section in Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.424

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.435

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 30. Issue 1.

Pages 1-48 (January - February 2018)

Originals

Causes of failure to achieve the low density lipoprotein cholesterol therapeutic target in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. EROMOT study

Clotilde Morales, Núria Plana, Anna Arnau, Laia Matas, Marta Mauri, Àlex Vila, Lluís Vila, Cristina Soler, ... on behalf of the EROMOT-XULA research group

Clin Investig Arterioscler. 2018;30:1-9

Full text access

Open Article

The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats

Gema Marín-Royo, Ernesto Martínez-Martínez, Beatriz Gutièc)rrez, Raquel Jurado-López, Isabel Gallardo, Olimpio Montero, Mª Visitación Bartolomèc), Josèc) Alberto San Román, ... Victoria Cachofeiro

Clin Investig Arterioscler. 2018;30:10-20

Full text access

Open Article

Association between endothelial dysfunction, epicardial fat and subclinical atherosclerosis during menopause

Julio Oscar Cabrera-Rego, Daisy Navarro-Despaigne, Liudmila Staroushik-Morel, Karel Díaz-Reyes, Marcos M. Lima-Martínez, Gianluca Iacobellis

Clin Investig Arterioscler. 2018;30:21-7

Full text access

Open Article

Editorial

In search of the “metabolic footprint” in cardiovascular disease

Manuel Vázquez Carrera

Clin Investig Arterioscler. 2018;30:28-9

Full text access

Open Article

Review article

Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration

Jesus Millan, Xavier Pintó, Angel Brea, Mariano Blasco, Antonio Hernández Mijares, Juan Ascaso, Angel Diaz, Teresa Mantilla, Juan Pedro-Botet

Clin Investig Arterioscler. 2018;30:30-5

Full text access

Open Article

Special article

Homogenization of the lipid profile values

Juan Pedro-Botet, Luis Rodríguez-Padial, Carlos Brotons, Margarita Esteban-Salán, Aurora García-Lerín, Xavier Pintó, Iñaki Lekuona, Jordi Ordóñez-Llanos

Clin Investig Arterioscler. 2018;30:36-48

Full text access

Open Article

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter